INTRODUCTION: Chronic granulomatous disease is a rare inherited immunodeficiency syndrome caused by mutations in four genes encoding essential nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex components. MATERIAL AND METHODS: Clinical, functional, and molecular investigations were conducted in 15 Jordanian CGD patients from nine families. RESULTS AND DISCUSSION: Fourteen patients were children of consanguineous parents and suffered from autosomal recessive (AR) CGD forms with mutations in the CYBA, NCF1, and NCF2 genes encoding p22phox, p47phox, and p67phox proteins, except for one patient in whom the mutation's location was not found. One patient had an extremely rare X(+)CGD subtype resulting from a novel missense mutation (G1234C) in exon 10 of CYBB. We found a genetic heterogeneity in the Jordanian families with a high frequency of rare ARCGD, probably because consanguineous marriages are common in Jordan. No clear correlation between the severity of the clinical symptoms and the CGD types could be established.
INTRODUCTION:Chronic granulomatous disease is a rare inherited immunodeficiency syndrome caused by mutations in four genes encoding essential nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex components. MATERIAL AND METHODS: Clinical, functional, and molecular investigations were conducted in 15 Jordanian CGDpatients from nine families. RESULTS AND DISCUSSION: Fourteen patients were children of consanguineous parents and suffered from autosomal recessive (AR) CGD forms with mutations in the CYBA, NCF1, and NCF2 genes encoding p22phox, p47phox, and p67phox proteins, except for one patient in whom the mutation's location was not found. One patient had an extremely rare X(+)CGD subtype resulting from a novel missense mutation (G1234C) in exon 10 of CYBB. We found a genetic heterogeneity in the Jordanian families with a high frequency of rare ARCGD, probably because consanguineous marriages are common in Jordan. No clear correlation between the severity of the clinical symptoms and the CGD types could be established.
Authors: R El Kares; M R Barbouche; H Elloumi-Zghal; M Bejaoui; J Chemli; F Mellouli; N Tebib; M S Abdelmoula; S Boukthir; Z Fitouri; S M'Rad; K Bouslama; H Touiri; S Abdelhak; M K Dellagi Journal: J Hum Genet Date: 2006-08-26 Impact factor: 3.172
Authors: Marie José Stasia; Bernard Lardy; Andres Maturana; Pascale Rousseau; Cécile Martel; Pierre Bordigoni; Nicolas Demaurex; Françoise Morel Journal: Biochim Biophys Acta Date: 2002-04-24
Authors: Clara Bionda; Xing Jun Li; Robin van Bruggen; Michel Eppink; Dirk Roos; Françoise Morel; Marie-José Stasia Journal: Hum Genet Date: 2004-08-24 Impact factor: 4.132
Authors: Najla S Dar-Odeh; Wail A Hayajneh; Osama A Abu-Hammad; Huda M Hammad; Adel M Al-Wahadneh; Najwa K Bulos; Azmi M Mahafzah; Maha S Shomaf; Mohammed A El-Maaytah; Faris G Bakri Journal: BMC Res Notes Date: 2010-02-17
Authors: Dirk Roos; Douglas B Kuhns; Anne Maddalena; Joachim Roesler; Juan Alvaro Lopez; Tadashi Ariga; Tadej Avcin; Martin de Boer; Jacinta Bustamante; Antonio Condino-Neto; Gigliola Di Matteo; Jianxin He; Harry R Hill; Steven M Holland; Caroline Kannengiesser; M Yavuz Köker; Irina Kondratenko; Karin van Leeuwen; Harry L Malech; László Marodi; Hiroyuki Nunoi; Marie-José Stasia; Anna Maria Ventura; Carl T Witwer; Baruch Wolach; John I Gallin Journal: Blood Cells Mol Dis Date: 2010-08-21 Impact factor: 3.039
Authors: Douglas B Kuhns; Amy P Hsu; David Sun; Karen Lau; Danielle Fink; Paul Griffith; Da Wei Huang; Debra A Long Priel; Laura Mendez; Samantha Kreuzburg; Christa S Zerbe; Suk See De Ravin; Harry L Malech; Steven M Holland; Xiaolin Wu; John I Gallin Journal: Blood Adv Date: 2019-01-22
Authors: Dirk Roos; Douglas B Kuhns; Anne Maddalena; Jacinta Bustamante; Caroline Kannengiesser; Martin de Boer; Karin van Leeuwen; M Yavuz Köker; Baruch Wolach; Joachim Roesler; Harry L Malech; Steven M Holland; John I Gallin; Marie-José Stasia Journal: Blood Cells Mol Dis Date: 2010-02-18 Impact factor: 3.039